Thrombotic thrombocytopenic purpura and defective apoptosis due to CASP8/10 mutations: the role of mycophenolate mofetil

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome2016 · 96 citations
2. 2The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura2015 · 127 citations
3. 3Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia2012 · 345 citations
4. 4Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience2015 · 68 citations
5. 5Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus2017 · 53 citations